Immunotherapy side effects research study
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study collects blood, stool, and tissue samples from people who have had side effects from immunotherapy (a type of cancer treatment that helps your immune system fight cancer). It aims to learn more about these side effects, so doctors can better manage them in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning to receive or have already received immunotherapy (a treatment that boosts your immune system to fight cancer).
- You have not had certain types of immunotherapy before (like CTLA-4, PD-1, or PD-L1 inhibitors) unless you are joining after starting treatment for the first time.
- You are willing to give blood and stool samples at the start of the study (and possibly more later).
- If you have already had immunotherapy, you must have experienced a significant side effect thought to be related to that treatment, such as a severe immune reaction, certain moderate side effects affecting skin, hormones, or joints, a rare infection, or unusually fast tumor growth.
- You have not been enrolled in this study before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tries to predict who is more likely to get serious side effects from immune checkpoint medicines used for solid tumors. You may help researchers by answering questionnaires before treatment and during follow-up, and by possibly storing sample specimens.
This study looks at how immune-related side effects happen in people treated with certain cancer immunotherapies. It also includes some healthy volunteers and people who already have similar autoimmune conditions, to better understand and compare these reactions.
This study looks at side effects from immune checkpoint inhibitors in people with solid tumors. It aims to understand why side effects happen and who might be at risk, so doctors can better manage them.
This study is a registry that collects information on immune-related side effects in cancer patients receiving immunotherapy. It helps doctors understand and manage these side effects better.
This study looks at how side effects happen in people receiving immune checkpoint inhibitor immunotherapy for solid cancers. It uses multiple types of tests to better understand these toxicities and may help improve safety and care in the future.
This study watches people with solid tumors who are starting immunotherapy for the first time. It aims to predict and better understand side effects and how well the treatment works, to help doctors manage care more effectively.
Hear when a new Hematopoietic and Lymphoid Cell Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.